802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
Status:
Not yet recruiting
Trial end date:
2026-09-29
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the efficacy of BIIB074 in treating pain
experienced by participants with trigeminal neuralgia (TN).
The secondary objectives are to investigate the safety and tolerability of BIIB074 in
participants with TN and to evaluate the population pharmacokinetic(s) (PK) of BIIB074.